Clinical Trial: NAD Supplementation in Parkinson's Disease

U.S., July 15 -- ClinicalTrials.gov registry received information related to the study (NCT07703137) titled 'NAD Supplementation in Parkinson's Disease' on June 26.

Brief Summary: The goal of this clinical trial is to learn whether Nicotinamide Riboside, a form of Vitamin B3 also known as NR, can improve blood vessel health in the brain, memory, and physical function in eligible study participants. NR is considered investigational for this study because it is not yet established for this specific use.

The main questions it aims to answer are:

Can NR improve non-invasive measures of blood vessel health in the brain? Can NR improve memory testing results and physical function?

Researchers will compare participants who receive NR with part...